Screener
Intellia Therapeutics NTLA Market capitalization
Market capitalization at other companies
Other financials
Where this comes from
Computed from the period-end share price: $2.36B.
The source filing: Intellia Therapeutics’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:05 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-337952
FAQ
- What is Intellia Therapeutics's market capitalization?
- Intellia Therapeutics (NTLA) reported market capitalization of $2.36B in Q2 2026.
- How has Intellia Therapeutics's market capitalization changed year-over-year?
- Intellia Therapeutics's market capitalization increased by 138.5% year-over-year, from $991.29M to $2.36B.
- What is the long-term trend for Intellia Therapeutics's market capitalization?
- Over 5 years (2020 to 2025), Intellia Therapeutics's market capitalization has grown at a -23.8% compound annual growth rate (CAGR), from $4.05B to $1.04B.
- What does market capitalization mean?
- The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.
Ask your AI about Intellia Therapeutics's market capitalization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude